Polypeptide hormone phosphatonin
The present invention relates to a novel human protein called phosphatonin, and isolated polynucleotides encoding this protein. Also provided are vectors, host cells, antibodies, and recombinant methods for producing this human protein. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to this novel human protein.
1. A method of treatment, comprising the steps of:
administering to a patient a therapeutically effective amount of a formulation comprising a carrier and a polypeptide having phosphatonin activity; and
allowing the formulation to effect phosphate metabolism in the patient.
2. The method of claim 1 , wherein the polypeptide has a molecular weight in the range of from about 53 to 60 kDa as measured by SDS-PAGE.
3. The method of claim 1 , wherein the polypeptide has a molecular weight of about 200 kDa as measured by bis-tris SDS-PAGE at pH 7.
4. The method of claim 1 , wherein the polypeptide comprises SEQ ID NO:2.
5. The method of claim 1 , wherein the polypeptide is glycosylated.
6. The method of claim 1 , wherein the polypeptide is phosphorylated.
7. The method of claim 1 , wherein the polypeptide is phosphorylated and glycosylated.
8. The method of claim 1 , wherein said polypeptide has an amino acid sequence that is at least 90% identical to the contiguous amino acid sequence set forth in SEQ ID NO:2.
9. An isolated polypeptide having phosphatonin activity which polypeptide is glycosylated.
10. The polypeptide of claim 9 which polypeptide is phosphorylated.
11. An isolated polypeptide having phosphatonin activity which polypeptide is phosphorylated.
12. The polypeptide of claim 9 , comprising SEQ ID NO:2.
13. The polypeptide of claim 9 , encoded by a polynucleotide sequence chosen from a polynucleotide sequence comprising SEQ ID NO:1 and a polynucleotide sequence which hybridizes to SEQ ID NO:1 under stringent hybridization conditions and wherein the polypeptide has phosphatonin activity.
14. An isolated polypeptide comprising a fragment of SEQ ID NO:2 chosen from amino acid residues 1 to 40, 141 to 180 and 401 to 429.
15. An isolated polypeptide comprising a fragment of SEQ ID NO:2 wherein the fragment has phosphatonin activity.
16. The polypeptide of claim 15 , wherein the fragment is chosen from fragments 20-30, 100-130, 145-160, 300-310, 320-340 and 380-430 of SEQ ID NO:2.
17. The polypeptide of claim 15 , wherein the fragment is a C-terminal fragment.
18. The polypeptide of claim 15 , wherein the fragment is an N-terminal fragment.